Rep. Mikie Sherrill

Maddy summaryHR 6088, the *Restoring Food Security for American Families and Farmers Act of 2025*, repeals specific sections (10101-10108) from a prior reconciliation law. This action revives previous provisions related to food security programs that were modified by those repealed sections. The bill directly affects federal food assistance and agricultural support programs by restoring their prior legal framework. It does not create new policies but reverses recent changes to existing food security measures.

Maddy summaryHR 909, the Crime Victims Fund Stabilization Act of 2025, modifies how funds from the False Claims Act are deposited into the Crime Victims Fund. It specifies that from 2025 through 2029, certain False Claims Act proceeds (specifically those for qui tam plaintiff payments and government damage reimbursements) cannot be deposited into the fund. This change directly affects the composition of the Crime Victims Fund by excluding these specific revenue streams during the specified period. The bill does not create new benefits or alter victim services; it only adjusts fund allocation rules for existing False Claims Act revenues.

Maddy summaryHR 4611 (EACH Act of 2025) requires all federally funded health programs - including Medicaid, Medicare, military health plans, and the Indian Health Service - to cover abortion services without restrictions, repealing the Hyde Amendment's long-standing ban on federal funding for most abortions. This directly affects millions of people enrolled in these programs, particularly low-income women, women of color (including 25% of Black women and 22% of Hispanic women on Medicaid), and young people. The bill mandates coverage in all federally administered health plans and prohibits state or private insurers from restricting abortion coverage in health insurance. It aims to eliminate current federal and state barriers that deny abortion access to people who rely on government health programs.

Maddy summaryThe Protect America's Workforce Act cancels an executive order issued on March 27, 2025, that excluded certain groups from federal labor-management relations programs, making it legally unenforceable. It also ensures that all collective bargaining agreements between federal agencies and labor unions, which were active as of March 26, 2025, remain fully effective until their agreed terms expire. This directly affects federal agencies, labor unions, and the employees covered by these agreements. The bill prevents federal funds from being used to implement the canceled executive order while preserving existing labor agreements.

Miracle on Ice Congressional Gold Medal Act This act provides for the award of Congressional Gold Medals to the members of the 1980 U.S. Olympic men's ice hockey team in recognition of the team's achievement at the 1980 Winter Olympic Games.

Maddy summaryThis bill authorizes the placement of a memorial honoring women who supported the U.S. war effort during World War II (including those working as pilots, engineers, and in factories) on federal land in Washington, D.C. It specifies two locations: Area I on the National Mall map or the National Mall Reserve, as defined in existing law. The memorial was previously authorized by Section 702 of the 2023 Consolidated Appropriations Act (Public Law 117-328), and this bill clarifies its permitted locations.

Maddy summaryThis bill directs the American Battle Monuments Commission to correct historical errors by identifying Jewish World War I and II veterans buried overseas under incorrect Christian markers (Latin crosses) and replacing them with appropriate markers. It establishes a 10-year program to contact families of affected veterans, with the Commission funding the effort at $500,000 annually through nonprofit contracts. The program specifically targets veterans buried in foreign U.S. military cemeteries with markers indicating non-Jewish faith, addressing a documented mistake affecting approximately 900 Jewish servicemembers. This directly affects Jewish veterans' families by honoring their heritage and correcting past burial inaccuracies.

Maddy summaryThis bill (HR 249) renames two specific facilities at Paterson Great Falls National Historical Park in honor of the late Congressman Bill Pascrell, Jr. The Great Falls Scenic Overlook Trail Bridge will be called "Bill Pascrell, Jr. Scenic Overlook Trail Bridge," and Overlook Park will be called "Bill Pascrell, Jr. Overlook Park." All federal references in laws, maps, documents, or records will automatically update to reflect these new names. As a procedural naming bill, it has no policy or funding impact beyond the official renaming of park features.

Maddy summaryThis bill renames a U.S. Postal Service facility at 514 Frelinghuysen Avenue in Newark, New Jersey, as the "Mildred Joyce Coleman Crump Post Office Building." All official references in federal documents, maps, or records to this specific post office location will now use the new name. The bill directly affects the Newark postal facility and its official documentation. (Procedural naming resolution; no policy changes.)

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)